Skip to content
  • Tuesday, 21 April 2026
  • 3:45 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Expands In Vivo Gene Therapy Arsenal with $7 Billion Acquisition of Kelonia Therapeutics
Pharmaceutical R&D

Eli Lilly Expands In Vivo Gene Therapy Arsenal with $7 Billion Acquisition of Kelonia Therapeutics

Teuku Ryan Apr 21, 2026 0

Eli Lilly and Company has significantly bolstered its position in the rapidly evolving cell and gene therapy (CGT) landscape with…

Read More
Pharmaceutical R&D

The Dawn of In Vivo Cell Therapies: A New Era in Precision Medicine Unfolds Amidst Significant Investment and Innovation

Teuku Ryan Apr 18, 2026 0

The pharmaceutical landscape is witnessing a profound transformation with the ascendance of in vivo cell therapies, a revolutionary approach that…

Read More
Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain TumorsUnlocking Ancient Secrets: New Study Reveals Deep Evolutionary Conservation of Regulatory DNA in PlantsUnveiling the Ancient Architects of Plant Life: Breakthroughs in Deep Time Genetics Reveal Enduring Regulatory DNAGilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityLLMOps in 2026: The 10 Tools Every Team Must HaveWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Scientists Replicate Human Bone Marrow Complexities in Groundbreaking Lab-Grown ModelCancer Scientists Unanimously Advocate for Sustained Congressional Funding at AACR Annual Meeting in San DiegoInsilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’Innovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical Study
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Scientists Replicate Human Bone Marrow Complexities in Groundbreaking Lab-Grown Model
Dwi Wanna Apr 21, 2026
Biotech & Genetic Research
Cancer Scientists Unanimously Advocate for Sustained Congressional Funding at AACR Annual Meeting in San Diego
Jia Lissa Apr 21, 2026
Laboratory Automation & Robotics
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
Lana Keisha Apr 21, 2026
Neuroscience & Brain Research
Innovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical Study
Rifan Muazin Apr 21, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ